These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18006818)

  • 1. Examination of IGF2 and H19 loss of imprinting in bladder cancer.
    Byun HM; Wong HL; Birnstein EA; Wolff EM; Liang G; Yang AS
    Cancer Res; 2007 Nov; 67(22):10753-8. PubMed ID: 18006818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
    Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
    Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
    Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
    Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers.
    Sasamoto H; Nagasaka T; Notohara K; Ozaki K; Isozaki H; Tanaka N; Matsubara N
    Int J Oncol; 2004 Nov; 25(5):1273-8. PubMed ID: 15492815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
    Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
    Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
    Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
    Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
    Tessema M; Länger F; Bock O; Seltsam A; Metzig K; Hasemeier B; Kreipe H; Lehmann U
    Int J Oncol; 2005 Feb; 26(2):499-507. PubMed ID: 15645136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W; Fan H; He X; Zhang J; Xie W
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
    Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
    Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.
    Constância M; Dean W; Lopes S; Moore T; Kelsey G; Reik W
    Nat Genet; 2000 Oct; 26(2):203-6. PubMed ID: 11017078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of IGF2 imprinting: mechanisms and consequences.
    Ohlsson R
    Novartis Found Symp; 2004; 262():108-21; discussion 121-4, 265-8. PubMed ID: 15562825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of p57(KIP2)mRNA in human bladder cancer.
    Oya M; Schulz WA
    Br J Cancer; 2000 Sep; 83(5):626-31. PubMed ID: 10944603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.